+1 Hunterr, I think DCB is the right guy for the job - and I would suggest anyone on this forum that has spoke to him directly probably feels the exact same way. also I’d suggest it is a pretty steep learning curve being a CEO for the first time so I think subsequent announcements are probably going to be more refined based off feedback from this quarterly.
All data aside, I do think IMU probably has “more going on” if you think about what’s happening in the clinic but, I think we are absolutely one of the leaders on the asx. Though, I think with the scientific advisory board we will create and the significant team that’s being built around us we are going to be the leader in the next 12 months.
Ann: Quarterly Activity Report & Appendix 4C, page-102
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.055(3.61%) |
Mkt cap ! $250.5M | |||
| Open | High | Low | Value | Volume |
| $1.53 | $1.58 | $1.46 | $143.9K | 96.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 230 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 550 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |